Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Thomas I. Barron"'
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 4 (2012)
The purpose of this review is to present the preclinical, epidemiological and clinical data relevant to the association between β-blockers and breast cancer progression. Preclinical studies have shown that β-adrenergic receptor (β-AR) signalling c
Externí odkaz:
https://doaj.org/article/26a03cde7f194ccc9ab4947fd53379bf
PDF file - 56K, Sensitivity Analysis: Inclusion of stage IV and unspecified stage patients.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::072fb1f32d9f1d8f65f14d0aabf52296
https://doi.org/10.1158/1055-9965.22437648
https://doi.org/10.1158/1055-9965.22437648
PDF file - 47K, Characteristics of the full study cohort according to diabetes status and exposure to metformin.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d123d31137866b28e2e373a3661851e
https://doi.org/10.1158/1055-9965.22437654.v1
https://doi.org/10.1158/1055-9965.22437654.v1
Autor:
Linda Sharp, Kala Visvanathan, Kathleen Bennett, Chris Brown, Laura M. Murphy, Thomas I. Barron
Study covariate and outcome definitions.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f2a5705e81fbc297912de145f5d4039
https://doi.org/10.1158/1055-9965.22437370
https://doi.org/10.1158/1055-9965.22437370
PDF file - 37K, Sensitivity Analysis: Study of de novo post-diagnostic metformin exposure.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b510c1d8788f6323cedca5c0ea0b55ea
https://doi.org/10.1158/1055-9965.22437645.v1
https://doi.org/10.1158/1055-9965.22437645.v1
Background: Preclinical evidence suggests a beneficial effect of metformin in colorectal cancer. This study aimed to investigate associations between metformin exposure and colorectal cancer–specific survival using population-level data.Methods: Ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d1feb267ade6bd8217cdaf49a2fec03
https://doi.org/10.1158/1055-9965.c.6515988
https://doi.org/10.1158/1055-9965.c.6515988
PDF file - 58K, Sensitivity Analysis: Varying definition of cause of death; CRC deaths additionally classified with the inclusion of (i) all deaths where CRC was identified as a secondary cause of death ('Definition 2'), (ii) deaths due to malignant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d179e0162db147eb723372ba06b9d7a
https://doi.org/10.1158/1055-9965.22437651
https://doi.org/10.1158/1055-9965.22437651
Autor:
Linda Sharp, Kala Visvanathan, Kathleen Bennett, Chris Brown, Laura M. Murphy, Thomas I. Barron
Background: Aspirin use has been associated with significant reductions in breast cancer–related mortality in some observational studies. However, these studies included women who initiated aspirin use before breast cancer diagnosis. It is unclear
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81a7171beac87de76c6e24c3a43ab084
https://doi.org/10.1158/1055-9965.c.6515842
https://doi.org/10.1158/1055-9965.c.6515842
PDF file - 25K, WHO ATC drug codes, tumour site and tumour morphology definitions.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67426907479209a939c2a3621f01e1da
https://doi.org/10.1158/1055-9965.22437657
https://doi.org/10.1158/1055-9965.22437657
Publikováno v:
British Journal of Cancer
Background: Recent meta-analyses suggest that pre-diagnostic statin use is associated with reduced breast cancer-specific mortality. Studies have shown that high breast tumour expression of the statin target (3-hydroxy-3-methylglutaryl coenzyme-A red
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f941447b63d0678330d57cd5d7e79f4
http://europepmc.org/articles/PMC5558692
http://europepmc.org/articles/PMC5558692